A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

LICORbio, a leading innovator in life science imaging and analytical solutions, today announced the acquisition of SERVA Electrophoresis, a privately held company known for its high-quality ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...

A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the ...

Terrana Biosciences will develop crop protection inputs using RNA technology, which was used by Flagship portfolio company Moderna to develop its covid-19 vaccine.

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

With more than 2,100 members, EMBO stands for excellence in the life sciences. It accepts outstanding researchers who are ...

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

Assessing the distribution of a medication in the brain is critical for the treatment of a vast range of neurological ...

Terrana is aiming to have commercially available products in the next few years, pending regulatory approval, that can be applied as sprayables or seed treatments. And the company says its RNA-based ...

For payers, claims for rare disease treatments used to be uncommon. Not anymore, thanks to an increasing number of new, ...